| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002505 | American Journal of Ophthalmology | 2014 | 9 Pages |
Abstract
The results of this study show that 2% rebamipide is effective in improving both the objective signs and subjective symptoms of dry eye patients for at least 52Â weeks. In addition, 2% rebamipide treatment was generally well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Shigeru Kinoshita, Saki Awamura, Norihiro Nakamichi, Hiroyuki Suzuki, Kazuhide Oshiden, Norihiko Yokoi, Rebamipide Ophthalmic Suspension Long-term Study Group Rebamipide Ophthalmic Suspension Long-term Study Group,